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INTRODUCTION
Virus infection triggers a complex cascade in which
the host’s immune system is deployed in order to prevent
virus replication and dissemination. The initiation of a
self-destruct apoptotic program in infected somatic cells
represents a highly effective innate host response em-
ployed for curtailing infection. However, viruses have, in
turn, evolved diverse strategies to manipulate the host’s
apoptotic response to ensure their continued propaga-
tion (O’Brien, 1998; Roulston et al., 1999; Tortorella et al.,
2000). The ultimate outcome following infection therefore
depends on the balance between competing host and
viral influences on the cell death program.
Apoptotic signals can be classified as “extrinsic” if
triggered by death receptor engagement at the cell sur-
face or “intrinsic” if intracellular sensors are triggered
(Fig. 1) (Hengartner, 2000; Kroemer and Reed, 2000). The
precise nature of the “danger signals” that allow cells to
sense infection and consequently the need to initiate
apoptosis are varied (Everett and McFadden, 1999), but
the activation of apoptotic cascades appears to be an
unavoidable consequence of most infections and often
requires the development of viral anti-apoptotic de-
fenses. Extrinsic signals can be initiated by adsorption of
viral particles during the entry process at the plasma
membrane. Attachment of noninfectious, conformation-
ally intact human immunodeficiency virus (HIV), vaccinia
virus, and Herpes simplex virus (HSV) particles to the
surface of cells is proapoptotic (Esser et al., 2001; Ram-
sey-Ewing and Moss, 1998; Zhou et al., 2000). Receptor-
mediated death signaling also appears to be triggered
during entry of avian–leukosis–sarcoma virus, which at-
taches to cells by means of a TNF receptor-related pro-
tein, CAR1 (Brojatsch et al., 1996). Engagement of this
receptor by the viral envelope proteins is sufficient tot
a
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initiate apoptosis, although the exact details of the mech-
anisms involved await further investigation. Virus infec-
tion may also stimulate intrinsic cell death pathways
mediated by intracellular triggers such as (i) the double-
stranded RNA-activated protein kinase R (PKR) that is
activated by diverse viruses including influenza A virus
(Balachandran et al., 2000) and encephalomyocarditits
virus (Yeung et al., 1999), (ii) the endoplasmic reticulum
stress response that is activated by, for example, respi-
ratory syncytial virus (Bitko and Barik, 2001), (iii) nuclear
sensors such as p53 that detect genotoxic damage or
inappropriate transcriptional activation that are induced
by a number of viruses (Neil et al., 1997), and (iv) events
inked to mitochondria (Everett and McFadden, 2001).
Alterations in mitochondrial morphology and function
uring virus infection have been documented, but the
iological significance of these observations was not
lways clear. For example, mitochondrial heat shock
rotein induction during infection by a number of viruses
as reported (Jindal and Malkovsky, 1994) before it was
ealized that these effects could have implications for
poptotic processes (Xanthoudakis and Nicholson,
000). With the recognition that mitochondria play a pre-
minent role, not only in energy generation, but also in a
ell’s decision to die, attention has been focused more
losely on the regulation of mitochondrial functions (re-
iewed in Desagher and Martinou, 2000; Kroemer and
eed, 2000; Vander Heiden and Thompson, 1999). In this
inireview we focus on viral proteins that modulate
itochondrial apoptotic signals and either inadvertently
timulate cell death or inhibit this key pathway to prevent
ell death.
APOPTOSIS AND THE ROLE OF MITOCHONDRIA
Extrinsic and intrinsic apoptotic stimuli that are or-
hestrated by mitochondria frequently involve proteins
rom two distinct families: the caspase family of apopto-
ic proteases that coordinate proteolytic events during
poptosis and the Bcl-2 family of regulatory proteins (Fig.
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21). Cell death mediated by mitochondria is also accom-
panied by two prominent changes in this organelle that
may occur independently, but often are linked (Martinou
and Green, 2001; Zamzami and Kroemer, 2001). One of
the key mitochondrial changes associated with apopto-
sis is the efflux into the cytosol of proteins that are
normally sequestered in the intermembrane space be-
tween the inner and outer mitochondrial membranes.
Proteins involved in this redistribution include apoptotic
cofactors such as cytochrome c and Smac/Diablo, which
re both involved in the activation of the apoptotic pro-
ease, procaspase-9. Activated caspase-9 then amplifies
he apoptotic signal by cleaving and activating the effec-
or caspase, caspase-3, that is responsible for many of
he morphological changes characteristic of apoptosis.
n addition to these cofactors, mitochondria also release
poptotic effectors including procaspases-2, -3, and -9
FIG. 1. Extrinsic and intrinsic death signals transduced by mitochond
activation of caspase-8. This leads to Bid cleavage and tBid potentiates
tBid-mediated events may also be initiated by intrinsic triggers, althou
directly. One prominent mitochondrial change is the perturbation of the
anion carrier (VDAC) that resides in the outer mitochondrial membra
cyclophilin D (CPD) that is associated with the matrix surface of the AN
peripheral benzodiazepine receptor (PBR). The other mitochondrial cha
Smac/Diablo. Cytochrome c and Smac/Diablo activate procaspase-9 th
actor (AIF) is also released from mitochondria and initiates a down
ntiapoptotic Bcl-2 proteins.
MINs well as apoptosis-inducing factor (AIF), a protein that
riggers caspase-independent apoptotic events in the Bucleus (Martinou and Green, 2001; Zamzami and Kro-
mer, 2001). The other notable mitochondrial change that
an be observed is the abrupt loss of the electrochemi-
al potential (DCm) normally maintained across the inner
embrane (Zamzami and Kroemer, 2001). The loss of
Cm occurs as a result of the sudden opening of a
itochondrial megachannel referred to as the perme-
bility transition (PT) pore. The PT pore consists of three
ore components: the voltage-dependent anion carrier
VDAC) that resides in the outer mitochondrial mem-
rane, the adenine nucleotide transporter (ANT) in the
nner membrane, and cyclophilin D (CPD) that is associ-
ted with the matrix surface of the ANT (Crompton, 1999).
Mitochondrial cell death events are tightly regulated
y the Bcl-2 family of proteins (Gross et al., 1999; Harris
and Thompson, 2000; Crompton, 2000). Members of this
family have opposing properties and tend to be antiapop-
the prototypal extrinsic pathway, death receptor ligation results in the
d/or Bak oligomerization in the outer mitochondrial membrane. These
nsic triggers are diverse and may also induce mitochondrial changes
bility transition (PT) pore. This pore consists of the voltage-dependent
adenine nucleotide transporter (ANT) in the inner membrane, and
ssory proteins include hexokinase (HK), creatine kinase (CK), and the
volves the release of apoptogenic proteins such as cytochrome c and
rn, activates the main effector caspase, caspase-3. Apoptosis-inducing
effect in the nucleus. Mitochondrial integrity can be preserved by
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IREVIEtotic (e.g., Bcl-2 and Bcl-XL) or proapoptotic (e.g., Bax,
ak, and Bid). The activation of proapoptotic members of
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V Indthe Bcl-2 family frequently serves as a convergence point
for extrinsic and intrinsic signals, a common event in
both pathways often being the interaction of the pro-
apoptotic proteins Bax and/or Bak with the outer mito-
chondrial membrane to amplify the apoptotic signal. The
proapoptotic effects of Bak and Bax are potentiated by
Bid, another Bcl-2 family member that undergoes cleav-
age to liberate the active form of the protein tBid. In the
prototypal extrinsic pathway, this cleavage is mediated
by caspase-8 that is activated following death receptor
engagement. Intracellular signals leading to Bid activa-
tion are varied and less well defined, but, for example,
Bid activation can be directly induced by granzyme B
during cell death mediated by cytotoxic T lymphocytes
(Heibein et al., 2000).
The molecular mechanisms underlying the regulatory
properties of Bcl-2 proteins are poorly understood and
two main theories have been proposed to account for the
mitochondrial effects observed during apoptosis. The
first model postulates that proapoptotic Bcl-2 proteins
are able to form autonomous pores in the mitochondrial
outer membrane and promote DCm loss and cytochrome
efflux, whereas antiapoptotic Bcl-2 proteins antagonize
hese effects. The second model proposes that pro-
poptotic Bcl-2 proteins function by perturbing activity of
he preexisting PT pore (Martinou and Green, 2001;
amzami and Kroemer, 2001) with antiapoptotic Bcl-2
roteins acting to maintain PT channel activities. The
xact molecular events resulting from channel perturba-
T
Viral Proteins That Modulate th
Protein Virus
Bcl-2
ALF-1 Epstein–Barr virus
HRF-1 Epstein–Barr virus
1B19K Adenovirus
VS-Bcl-2 Herpesvirus saimiri
Mitochond
13II Human T cell leukemia virus
Apoptin Chicken anemia virus
4orf4 Adenovirus
6 Human papilloma virus
CP4 Herpes simplex virus 1
11L Myxoma virus
ef Human immunodeficiency virus
at Human immunodeficiency virus
PT por
Bx Hepatitis B virus
MIA Cytomegalovirus
pr Human immunodeficiency virus
MINions during apoptosis are also unclear. Put simply, are
Cm loss and release of apoptotic effector and cofactorproteins direct effects of channel opening, or do these
mitochondrial changes reflect an indirect process in
which channel modulation causes mitochondrial matrix
swelling and outer membrane rupture? The study of viral
proteins that intervene at the mitochondrial apoptotic
checkpoint is beginning to provide insight into the com-
plex mechanisms of mitochondrion-mediated cell death
(Table 1).
MITOCHONDRIAL MODULATION BY VIRAL
HOMOLOGS OF THE Bcl-2 FAMILY
Viral Bcl-2 homologues are likely candidates for mod-
ulating mitochondrial function and, indeed, several of
these proteins have a direct, proximal effect on mito-
chondrial function when expressed in cells indepen-
dently of any other viral proteins. For example, the
BHRF-1 protein of Epstein–Barr virus (EBV) exhibits both
antiapoptotic properties (Henderson et al., 1993) and
mitochondrial localization (Hickish et al., 1994) and the
related EBV protein BALF-1 is able to prevent mitochon-
drial changes associated with apoptosis and interacts
with Bax and Bak (Marshall et al., 1999). BHRF-1 and the
E1B19K protein of adenovirus, also a functional Bcl-2
homolog (Rao et al., 1992), were each shown to counter-
act apoptosis induced by reactive oxygen species, which
act to disrupt mitochondrial integrity (Dumont et al.,
1999). E1B19K does not normally associate with mito-
chondria. However, in response to the proapoptotic ef-
hondrial Apoptotic Checkpoint
Role in apoptosis
logs
ibition (Marshall et al., 1999)
ibition (Dumont et al., 1999)
ibition (Han et al., 1998; Perez and White, 2000)
ibition (Derfuss et al., 1998)
dulators
known (Ciminale et al., 1999)
uction (Danen-van Oorschot et al., 2000)
uction (Livne et al., 2001)
sitization/inhibition (Brown et al., 1997; Jackson et al., 2000)
ibition (Zhou and Roizman, 2000; Galvan and Roizman, 1998)
ibition (Everett et al., 2000)
uction/inhibition (Rasola et al., 2001; Geleziunas et al., 2001)
uction (Kruman et al., 1998; Macho et al., 1999)
lators
ibition/inhibition, binds VDAC (Diao et al., 2001; Rahmani et al., 2000)
ibition, binds ANT (Goldmacher et al., 1999)
uction/inhibition, binds ANT (Jacotot et al., 2000)
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calize so as to interact with Bax in the mitochondrial
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IREVIEouter membrane and provided a protective effect against
Bax-induced mitochondrial DCm loss and apoptosis
(Han et al., 1998). Interestingly, E1B19K was also found to
relocalize and interact with Bax following TNF-mediated
caspase-8 activation, but only after Bax had undergone a
conformational change induced by tBid. The E1B19K
interaction with the proapoptotic form of Bax was then
found to inhibit downstream apoptotic events such as
cytochrome c release and caspase-9 activation. (Perez
and White, 2000). The herpesvirus saimiri-encoded Bcl-2
homologue (HVS-Bcl-2) is another antiapoptotic regula-
tor (Nava et al., 1997) and stable expression of this viral
protein alone is able to protect Jurkat T cells from apo-
ptosis induced by Fas ligation, DNA damage, or oxygen
radical production (Derfuss et al., 1998). The protective
effects of this viral Bcl-2 protein are apparently centered
on mitochondria and include prevention of DCm loss,
cytochrome c translocation into the cytosol, and
caspase-3 activation.
OTHER VIRAL PROTEINS THAT MODULATE
MITOCHONDRIA
Viral proteins that influence the mitochondrial cell
eath control point also include to non-Bcl-2 homologs.
he p13II protein of human T cell leukemia/lymphotrophic
irus type 1 (HTLV-1) contains a novel mitochondrial tar-
eting signal that directs it to mitochondria (D’Agostino
t al., 2000). p13II expression induces mitochondrial
welling and clustering as well as DCm loss. However,
cytochrome c redistribution is not observed and the role
f this protein in apoptosis is yet to be established
Ciminale et al., 1999). The apoptosis-inducing protein,
apoptin, of chicken anemia virus induces cell death in a
caspase-dependent manner. However, in the presence
of caspase inhibitors, this protein is able to induce mi-
tochondrial DCm loss and cytochrome c redistribution as
late event following apoptosis induction which may
eflect activation of a default cell death pathway (Danen-
an Oorschot et al., 2000). The E4orf4 protein of adeno-
irus is also believed to activate caspase-dependent cell
eath. Interestingly, apoptotic mitochondrial changes
uch as cytochrome c release and production of reactive
xygen species induced by expression of this protein
equire caspase-8 activation but do not require
aspase-9 activity indicating that the postmitochondrial
vents can be caspase-independent (Livne et al., 2001).
he E6 transforming protein of human papillomavirus
HPV) type 16 sensitizes cells to apoptosis induced by
tractyloside, an ANT ligand that induces PT pore open-
ng and DCm loss. This effect is both p53- and caspase-
dependent and is counteracted by the PT pore inhibitor
cyclosporin A (Brown et al., 1997). In contrast, however,
4 MIN6 proteins from several oncogenic strains of HPV can
reempt apoptotic signals upstream of mitochondria bybinding to Bak and assisting in its degradation (Jackson
et al., 2000; Thomas and Banks, 1999).
Novel viral proteins are also implicated in inhibiting
mitochondrial perturbation and apoptosis. HSV-1 is
known to inhibit caspase-dependent and -independent
events following infection (Galvan et al., 2000; Zhou and
Roizman, 2000). However, when cells were infected by a
HSV variant that is unable to express the ICP4 protein,
the cells underwent apoptotic changes associated with
caspase-3 activation and DNA fragmentation. Mitochon-
drial involvement was demonstrated by the release of
cytochrome c and apoptotic effects could be blocked by
Bcl-2. The myxoma poxvirus protein M11L is a potent
virulence factor that is required to prevent apoptosis
during virus infection of leukocytes (Macen et al., 1996).
Stable expression of M11L independently of other viral
proteins revealed that this protein is localized to mito-
chondria and is able to inhibit apoptotic changes includ-
ing caspase-3 activation and DNA fragmentation caused
by the intrinsic apoptotic trigger staurosporine. M11L
inhibits DCm loss and the mitochondrial localization of
this protein is important for its function (Everett et al.,
2000). Preliminary results indicate that these antiapop-
totic effects occur as a result of direct modulation of the
PT pore components by M11L (Everett et al., submitted).
HIV encodes a number of apoptosis-modulatory pro-
teins that trigger mitochondrial cell death processes
(Badley et al., 2000; Basanez and Zimmerberg, 2001; Ferri
et al., 2000). The Nef protein is responsible for down-
regulation of cell-surface receptors and alteration of cel-
lular signaling. Recently, stable expression of Nef in
lymphocyte cell lines was found to sensitize these cells
to DCm loss and apoptosis induced by several chemical
gents (Rasola et al., 2001). Levels of the protective
roteins Bcl-2/Bcl-XL were depressed in Nef-expressing
cells and cell death could also be induced in the pres-
ence of caspase inhibitors, suggesting that Nef has mul-
tiple modes of action. Complex function is also sug-
gested by the reported ability of Nef to stimulate survival
pathways may outweigh its proapoptotic potential in
some circumstances (Geleziunas et al., 2001). Another
HIV protein, Tat, functions as a transactivator for viral
gene expression, but has also been implicated in trig-
gering apoptosis by a variety of mechanisms including
the mitochondrial cell death pathway. Specifically, stable
expression of Tat in hippocampal neurons induced
caspase-dependent cell death associated with an in-
crease in mitochondrial calcium levels and an accumu-
lation of reactive oxygen species (Kruman et al., 1998).
Involvement of the mitochondrial PT pore was suggested
in this study when apoptosis was prevented by cyclo-
sporin A, a PT pore inhibitor. In another study, Tat ex-
pression was found to sensitize T cells to apoptosis
mediated by serum withdrawal (Macho et al., 1999). Cell
Wdeath was caspase-independent and was associated
with an accumulation of Tat in mitochondria as well as
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IREVIEDCm loss and increased production of reactive oxygen
pecies. Involvement of the PT pore in Tat-induced cell
eath was demonstrated by the finding that protoporphy-
in IX, a ligand of the PBR subunit of the PT pore, could
ynergize with Tat in apoptosis induction.
The examples described above demonstrate the im-
ortance of the mitochondrial cell death checkpoint dur-
ng apoptosis and seem to implicate the PT pore. How-
ver, much of this evidence is indirect and involves the
se of chemical agonists or antagonists of the pore.
ore direct evidence to support the importance of PT
ore modulation in infected cells has been provided by
eports that several viral proteins associate directly with
omponents of the pore. The best documented of these
re the HBx protein of hepatitis B virus, which binds to
he VDAC, and the vMIA protein of HCMV and the Vpr
rotein of HIV, which each bind to the ANT.
DIRECT REGULATION OF THE PT PORE
BY VIRAL PROTEINS
The HBx protein is clearly implicated in the develop-
ent of hepatitis B virus-induced hepatocellular carci-
oma; however, its role in apoptosis remains controver-
ial as both pro- and antiapoptotic functions have been
ttributed to this protein (Roulston et al., 1999). Involve-
ent of HBx in the mitochondrial apoptotic control point
as revealed during two studies that characterized the
bility of HBx to localize to mitochondria and bind to
DAC (Rahmani et al., 2000; Takada et al., 1999). Both of
hese studies also showed that HBx overexpression in
uH7 human hepatocellular carcinoma cells induced
poptotic changes including perinuclear clustering of
itochondria, DCm loss, and DNA fragmentation. In con-
rast, another recent study showed that expression of
Bx in a variety of liver cell lines and primary hepato-
ytes protected these cells from apoptosis induced by
as, TNF, or serum withdrawal (Diao et al., 2001). Spe-
ifically, HBx was found to prevent caspase-8 and -3
ctivation and cytochrome c translocation into the cyto-
plasm. Interestingly, HBx did not protect cells from a
variety of chemical apoptotic stimuli. HBx was also
shown to upregulate the growth-stimulatory SAPK/JNK
pathway and was detectable in a complex containing
MEKK1, SEK1, SAPK, and 14-3-3 proteins. The growth-
promoting effect of HBx was dependent on the presence
of an intact 14-3-3 protein binding motif. These findings
suggest that HBx acts to promote survival stimuli rather
than to antagonize apoptosis. In view of this proposed
mechanism, it would be interesting to ascertain how HBx
is targeted to mitochondria and whether the function of
HBx is dependent on its mitochondrial localization.
MINRecently, a protein expressed by a newly identified
splice variant of the UL37 gene of human cytomegalovi-
t
irus (HCMV), designated vMIA, was shown to protect
cells from Fas-, TNF-, and doxorubicin-mediated apopto-
sis (Goldmacher et al., 1999). vMIA was found to localize
to mitochondria and physically associate with the ANT
subunit of the PT pore. Apoptotic events upstream of
mitochondria such as caspase-8 activation or Bid cleav-
age were not inhibited by vMIA, but this protein was able
to preserve ATP generation following apoptosis induc-
tion, inhibit the release of apoptogenic factors such as
cytochrome c from mitochondria, and prevent caspase-9
ctivation. These properties support the theory that vMIA
cts by inhibiting apoptosis at the mitochondrial control
oint, presumably by modulating the PT pore. This mito-
hondrial site of action was further reinforced by the
inding that deletion of a 23-amino-acid N-terminal do-
ain abolishes the targeting and function of this protein
Goldmacher et al., 1999). These findings are intriguing
ecause vMIA has no database homologues and no
equence similarity to any of the Bcl-2 family members
nd yet is highly conserved among different strains or
CMV (Hayajneh et al., 2001). Nevertheless, the exis-
ence of vMIA emphasizes the importance of the ANT in
poptosis and may anticipate the existence of a cellular
rotein with an analogous function that is yet to be
dentified.
Vpr has been implicated in diverse processes includ-
ng HIV replication, cell cycle regulation, and differentia-
ion (Badley et al., 2000). Studies of apoptosis in cells
xpressing Vpr have yielded disparate results and re-
ently a dual role for Vpr in modulating apoptosis has
een proposed (Conti et al., 2000). Specifically, Vpr is
elieved to prevent apoptosis at early times of expres-
ion, but, following prolonged or elevated levels of ex-
ression, is able to potentiate apoptosis. Interestingly,
ddition of purified Vpr or a synthetic Vpr peptide to
solated mitochondria or intact cells has been shown to
licit caspase-independent DCm loss and release of
itochondrial proteins including cytochrome c and AIF
Jacotot et al., 2000, 2001). Involvement of the PT pore
as suggested by the observation that Bcl-2 and the PT
ore inhibitors cyclosporin A and bongkrekic acid inhib-
ted these Vpr-induced effects. Also, when liposomes
econstituted with isolated PT pore complexes were ex-
osed to Vpr, increased liposome permeability was ob-
erved and this effect was reversed by cyclosporin A or
ongkrekic acid. A direct role for Vpr in modulating the
T pore was revealed when it was shown that purified
pr was capable of direct physical association with ANT
s well as a complex composed of VDAC and ANT when
dded to isolated mitochondria (Jacotot et al., 2000). This
inding interface has been identified and involves inter-
ction between a C-terminal portion of Vpr and the N-
5Werminal regulatory loop of ANT that is exposed to the
ntermembrane space (Jacotot et al., 2001).
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An emerging theme for the mitochondrial apoptotic
modulators of viral origin is that their activity seems to be
directed toward components of the PT pore. Most nota-
bly, viral proteins directed specifically toward apopto-
genic proteins released from mitochondria, such as cy-
tochrome c or AIF, have yet to be discovered. This may
reflect the relatively recent appreciation that cytochrome
c and AIF are important apoptotic cofactors. Alternatively,
viruses may deliberately avoid interfering with the activ-
ity of proteins that are also required for normal cellular
metabolic functions. By impacting the PT pore and mod-
ulating apoptosis without directly impairing such essen-
tial processes as electron transport, viruses may thwart
any cellular antiviral strategy aimed at limiting the energy
supply.
Recent advances in the elucidation of the molecular
players in apoptotic cascades have revealed a pivotal
role for mitochondria as a control point for relaying and
amplifying many of the cell death signals. With this
knowledge, it has become apparent that diverse viral
apoptotic modulators have independently evolved mech-
anisms to exploit this critical junction where cell death
pathways intersect. Viral proteins that directly modulate
mitochondrial function will continue to be valuable ex-
perimental tools for dissecting cell death pathways, par-
ticularly in terms of the “cause” vs “effect” controversy that
surrounds the precise role of the PT pore complex during
apoptosis.
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